# Abbott Laboratories (ABT) — Q4-2014 Earnings Results

**Report date:** 2015-01-29 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2014

## Post-Earnings Brief

### Headline

Abbott Labs Misses on EPS, Stock Up 4.26%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | -8.15% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed a commitment to innovation and market leadership. They acknowledged the EPS miss but highlighted ongoing strategic initiatives.

**Key quotes:**

> We are focused on maintaining our strong market position.

> Continued investment in innovation is key to our growth strategy.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Abbott Labs reported an EPS of $0.62, which was below expectations, leading to an 8.15% surprise. Despite this, the stock rose by 4.26%, likely driven by investor optimism regarding the company's long-term strategies and market position. The lack of guidance may leave some investors cautious, but management's focus on innovation could support future growth.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2014_